Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
- Weitere Titel
-
Validierung und Charakterisierung von monoklonalen Antikörpern zur zielgerichteten Behandlung von Krebsstammzellen und zur Entwicklung neuer Krebstherapien
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2022
- Schlagwort
-
Cancer
Stem cells
Monoclonal antibodies
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.26083/tuprints-00021677
- URN
-
urn:nbn:de:tuda-tuprints-216776
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Müller, Sandra Rita
- Kolmar, Harald
- Breuhahn, Kai
- Universitäts- und Landesbibliothek
Entstanden
- 2022
Ähnliche Objekte (12)
Cancer and anticancer : a discussion
Progress in anti-cancer chemotherapy
Targeting CDK9 for anti-cancer therapeutics
Inhibition of heme oxygenase-1 (HO-1) increases responsiveness of pancreatic cancer cells to anti-cancer treatment
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Iridium compounds as prospective anti-cancer agents
Progress in anti-cancer chemotherapy, Vol. 4
Molecular aspects of anti-cancer drug action
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Assessing the economic value of anti-cancer therapies
In-Silico Design of an Anti-Cancer Vaccine
Cancer and anticancer : a discussion
Progress in anti-cancer chemotherapy
Targeting CDK9 for anti-cancer therapeutics
Inhibition of heme oxygenase-1 (HO-1) increases responsiveness of pancreatic cancer cells to anti-cancer treatment
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Iridium compounds as prospective anti-cancer agents
Progress in anti-cancer chemotherapy, Vol. 4
Molecular aspects of anti-cancer drug action
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Assessing the economic value of anti-cancer therapies
In-Silico Design of an Anti-Cancer Vaccine
Cancer and anticancer : a discussion
Progress in anti-cancer chemotherapy
Targeting CDK9 for anti-cancer therapeutics
Inhibition of heme oxygenase-1 (HO-1) increases responsiveness of pancreatic cancer cells to anti-cancer treatment
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Iridium compounds as prospective anti-cancer agents
Progress in anti-cancer chemotherapy, Vol. 4
Molecular aspects of anti-cancer drug action
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Assessing the economic value of anti-cancer therapies